A new study suggests bariatric surgery may offer stronger long-term heart protection than GLP-1 drugs like Ozempic and Mounjaro.

Alkeus Pharmaceuticals, Inc., a biopharmaceutical company dedicated to preserving the sight of individuals impacted by retinal diseases, today announced that results from its clinical study of ...

MARYSVILLE, OH - February 24, 2026 - PRESSADVANTAGE - Sleep Better Marysville has announced the expansion of its sleep ...

Veterans struggling with trauma have historically relied on traditional treatments. But now, some are turning to a ...

Science’s success at staving off death from heart disease or cancer has made another diagnosis more likely: Dementia.

New research talks about a promising adjunctive treatment to help people to build a life that isn't run by OCD.

Most women experience the effects of menopause firsthand. However, the choice of treatment can be complicated, and research shows both benefits and risks.

A low-dose, single-pill combination proved to be as effective as — and in some cases, superior to — standard-dose monotherapy ...

The device is administered as a swallowable capsule that is filled with liquid by a physician and naturally leaves the body after approximately 4 months.

Luvesilocin is a subcutaneously-administered, proprietary prodrug of the psilocybin-like compound 4-OH-DiPT designed to target the serotonin 2A receptor.

DMT therapy significantly reduced major depressive disorder symptoms in a phase IIa trial. Learn more about this rapid-acting ...

Two large real-world analyses presented at ACTRIMS Forum 2026 shed new light on the multiple sclerosis (MS) care continuum, ...